Diagnostic and Therapeutic Delays in Patients With Hepatocellular Carcinoma

CONCLUSIONS: Diagnostic and therapeutic delays exceeding 3 months are common in patients with HCC; however, observed treatment delays do not seem to significantly impact overall survival.PMID:34077908 | DOI:10.6004/jnccn.2020.7689

Source: Journal of the National Comprehensive Cancer Network : JNCCN - June 2, 2021 Category: Cancer & Oncology Authors: Ashwin Rao Nicole E Rich Jorge A Marrero Adam C Yopp Amit G Singal Source Type: research